The AKT3 gene helps control how cells grow, stay alive, and respond to signals, with an especially important role in brain development. If this gene does not work properly, brain growth may be reduced, which can be linked to a smaller than usual head size, developmental delay, or learning difficulties in some people. Some AKT3 variants make growth signals too strong instead, and these are associated with brain overgrowth, seizures, and differences in brain structure. Effects vary depending on the specific variant.
What is a gene?
Within your DNA, a gene is a stretch that holds instructions your cells use to make molecules or regulate processes in the body. Some genes carry the directions for making proteins, the parts of cells that do much of the work. Other genes mainly control when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can shape how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
AKT3Gene function
What if the gene works
The AKT3 gene helps control cell growth, survival, and energy use. It is especially active in the brain, where it supports normal brain growth and nerve cell signaling.
Risk
What if the gene does not work
Changes in the AKT3 gene can cause brain overgrowth, sometimes on one side, and may lead to seizures and developmental differences. Milder or more severe variants can influence when features appear and how pronounced they are.
Treatment
What does that mean for your treatment
No treatment approach tied specifically to pathogenic variants in the AKT3 gene is currently established in clinical guidelines. The AKT3 gene is being studied as part of the PI3K-AKT-mTOR pathway, and pathway targeted drugs are under investigation in some cancers and growth conditions, but this has not led to routine AKT3 directed care.
Conditions associated with AKT3
Gene function
What if the gene works
In your body, the AKT3 gene helps cells respond to growth and survival signals, with especially strong activity in the brain. Its protein acts like an internal switch that tells cells when to grow, use nutrients, and stay balanced. This is a key part of AKT3 gene function in brain development and everyday cell signaling.
The AKT3 gene helps cells pass along messages from growth factors, which are chemical signals that tell cells how to act. This lets cells adjust growth and activity in an orderly way.
This gene is especially active in the brain, where it supports normal growth and organization of brain tissue. These steady signals help the brain develop and maintain its usual structure.
AKT3 signaling helps cells stay alive during normal day to day stress, such as shifts in nutrients or changing demands. It supports the cell’s usual self-protection systems so healthy tissues remain stable.
The AKT3 gene helps link growth signals to how cells take in nutrients and use them to make energy and cell parts. This helps match a cell’s workload to the fuel it has available.
What is a variant?
A genetic variant is a small change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the AKT3 gene can change how strongly its protein signal stays switched on or how much protein is available. Some variants make signaling overactive, which can push brain cells to grow more than usual, while loss-of-function variants reduce signaling because the protein is shortened, unstable, or scarce. This range helps explain why AKT3 gene variants can affect brain growth differently, with milder changes often causing less disruption and more severe changes sometimes linked to earlier or marked features.
How variants are linked to conditions
Certain pathogenic variants in the AKT3 gene cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus (MPPH) syndrome and related AKT3 gene brain overgrowth conditions, which often include developmental delay, seizures, and differences in brain structure. Other AKT3 gene changes have also been linked to isolated megalencephaly, while loss of one copy of the AKT3 gene can be associated with a smaller than expected head size.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the AKT3 gene. For many living with an AKT3 change, risk depends mainly on the exact genetic change rather than lifestyle, and a doctor or genetic counselor can help explain personal risk.
Inheritance of AKT3 variants
AKT3-related conditions are usually inherited in an autosomal dominant pattern, which means one altered copy of the AKT3 gene can be enough to cause the condition. If a parent carries a disease-causing AKT3 variant, each child has a 50% chance of inheriting it. In many families, though, an AKT3 gene variant appears for the first time in the child as a new, de novo change rather than being passed down from either parent. This pattern explains why AKT3 gene inheritance can look different from one family to another.
What does my AKT3 result mean for my family?
For AKT3, family impact depends on the kind of result. In the well-known inherited form, a disease-causing AKT3 change is usually dominant, so close relatives such as a parent, brother, sister, or child may also carry it and may wish to discuss testing. Many reported cases happen as a new change in the child, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the AKT3 gene, labs can do genetic testing for AKT3 variants using a blood or saliva sample. The lab reads the gene’s DNA sequence and checks for variants that may help explain certain growth or brain development findings, or clarify whether a variant runs in a family.
When should I consider getting a genetic test?
AKT3 testing may be considered if a child has unusual brain or head overgrowth, repeated seizures, delays in development, or scans showing abnormal brain growth. It can also help when one side of the brain or body is larger than the other, or when a close relative has a known AKT3 change.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal varies by the condition and the specific type of variant. Over time, the way the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, these results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, how strongly it acts, or how sensitive someone is to side effects. This is a common reason the same treatment may work well for one person, have less effect for another, or feel harder to tolerate.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in genes can affect a person’s response to medication. By examining relationships between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can support more informed, more personalized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the AKT3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices, so questions about symptoms, treatment side effects, or medication changes are best discussed with your doctor. AKT3 has been studied in cancer research for how tumor changes may affect response to some targeted treatments, but this is not established guidance for routine prescribing.
History
AKT3 was identified in the 1990s as one of the three human AKT genes, during a period when researchers were mapping key cell signaling pathways involved in growth and survival. From these first observations, research expanded steadily. Scientists initially studied AKT3 alongside AKT1 and AKT2, then recognized that it had a distinct pattern of activity, especially in brain tissue. Interest in the AKT3 gene grew further as genetic studies linked changes in this gene to differences in brain growth and to some cancers. Over time, this work helped place AKT3 within the broader history of precision medicine, where gene findings began to shape how doctors classify conditions more accurately.